Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  OTC Bulletin Board  >  Cannabis Science Inc    

 SummaryNewsCompany 
Company
Cannabis Science, Inc. develops cannabis pharmaceutical products.It is at the forefront of cannabinoid research and development.The company works with world authorities on phytocannabinoid science targeting critical illnesses, and adheres to scientific methodologies to develop, produce, and... 
More about the company
Latest news on CANNABIS SCIENCE INC
01/10 Senate Banking Committee Could Pave the Way to a Bankable Marijuana Industry
01/10 CANNABIS SCIENCE, INC. (OTCMKTS : CBIS) Files An 8-K Entry into a Material Defin..
01/09 CANNABIS SCIENCE : Collaborative Research Agreement with Dana Farber Cancer Inst..
01/09 CANNABIS SCIENCE, INC. : Entry into a Material Definitive Agreement, Other Event..
01/06 CANNABIS SCIENCE : CBIS) and Dana Farber/Harvard Cancer Center (DF/HCC) Announce..
2016 CANNABIS SCIENCE : Orders Multiple Greenhouse Structures for its 2nd Pilot 33,00..
2016 CANNABIS SCIENCE : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION A..
2016 CANNABIS SCIENCE : Congratulates our 45th President, Mr. Donald J. Trump and Mov..
2016 CANNABIS SCIENCE : to Begin In-House Clinical Research With IGXBio's GenePro FDA..
2016 CANNABIS SCIENCE : Negotiates an Additional 200 Acres in California and 100 Acre..
More news
Sector news : Bio Therapeutic Drugs
01/13DJNOVARTIS : Supreme Court to Weigh How Soon Firms Can Sell Copycat Biotech Drugs
01/12 Investors in big pharma, biotech look to ride out Trump storm
01/12DJHot Stocks to Watch in the U.S. and Canada
01/10 Regeneron CEO says Amgen not putting patients first in patent dispute
01/09DJCELGENE : Anticipates Slowing Sales Growth for Main Drug Revlimid
More sector news : Bio Therapeutic Drugs
Advertisement
Managers
NameTitle
Raymond C. Dabney President, Chief Executive Officer & Director
Robert Kane COO, Director & Vice President-Investor Relations
Benjamin C. K. Tam Chief Financial Officer, Secretary & Director
Richard Ogden Chief Scientific Officer
Allen A. Herman Chief Medical Officer
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
CANNABIS SCIENCE INC0
AMGEN, INC.5.79%115 062
GILEAD SCIENCES, INC.-0.84%93 553
CELGENE CORPORATION-2.67%87 334
REGENERON PHARMACEUTIC..-1.23%38 239
ACTELION LTD4.58%23 977
More Results